CN Patent

CN102746385B — 胸腺素α1活性片段环肽类似物及其聚乙二醇化衍生物

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2014-07-09 · 12y expired

What this patent protects

本发明涉及一类含有天然或者非天然氨基酸取代的胸腺素α1活性片段的环肽类衍生物，其制备方法，含他们的药物组合物，及它们在治疗或预防免疫缺陷、免疫功能低下等相关疾病的药物。

USPTO Abstract

本发明涉及一类含有天然或者非天然氨基酸取代的胸腺素α1活性片段的环肽类衍生物，其制备方法，含他们的药物组合物，及它们在治疗或预防免疫缺陷、免疫功能低下等相关疾病的药物。

Drugs covered by this patent

motixafortide-acetate (MOTIXAFORTIDE ACETATE)

Patent Metadata

Patent number: CN102746385B
Jurisdiction: CN
Classification: —
Expires: 2014-07-09
Drug substance claim: No
Drug product claim: No
Assignee: Institute of Pharmacology and Toxicology of AMMS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.